Why none of malaria vaccines are effective?

Most of vaccines that have been worked on have aimed to generate antibodies against the parasites

The dengue sting needs an out-of-the-box cure
ANI New Delhi
Last Updated : Jun 07 2016 | 4:14 PM IST

Have you ever thought why none of the vaccines developed for malaria till date has protected against the disease for long? The scientists at QIMR Berghofer Medical Research Institute believe they have found the answer for this.

The discovery potentially paves way for more effective vaccines down the track.

Malaria is caused by parasites that are spread by mosquitoes.

Researchers have been trying to develop a successful vaccine for decades. However, even the most trialled vaccine remained effective even four years after immunisation in a small proportion of people.

Most of the vaccines that have been worked on have aimed to generate antibodies against the parasites.

Dr. Michelle Wykes, the head of the Molecular Immunology Laboratory, along with Joshua Horne-Debets and Deshapriya Karunarathne, found that activating immune cells known as CD8+ T cells was crucial in protecting mice against malaria in the longer term.

"This is the first time there has been evidence to show these immune cells are crucial for protecting against blood stage malaria - which is when symptoms start to show - in the long term. In other words, we've found that antibodies on their own aren't enough to maintain protection against malaria," said Dr. Wykes.

The World Health Organisation (WHO) estimates that malaria caused the deaths of 4,38,000 people and infected 214 million people worldwide in 2015.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 07 2016 | 4:01 PM IST

Next Story